Zevra Therapeutics Inc (FRA:1GDA)
€ 4.44 -0.04 (-0.89%) Market Cap: 181.24 Mil Enterprise Value: 173.39 Mil PE Ratio: 0 PB Ratio: 3.99 GF Score: 52/100

KemPharm, Inc. - Special Call Transcript

Mar 13, 2019 / 12:30PM GMT
Release Date Price: €1.85 (+6.94%)
Operator

Good day, ladies and gentlemen, and welcome to the KemPharm Apadaz Commercial Update Call. (Operator Instructions) As a reminder, today's conference may be recorded.

I'd now like to introduce your host for today's conference, Mr. Jason Rando. Sir, please go ahead.

Jason Rando
Tiberend Strategic Advisors, Inc. - COO & EVP

Good morning, and thank you for joining today's Apadaz Commercial Update Call.

Before we begin, I would like to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties and are subject to changes at any time including, but not limited to, statements about KemPharm's expectations regarding future operating results. Forward-looking statements are made pursuant to the Safe Harbor provisions of the federal securities laws and represent management's current expectations. Actual results may differ materially. KemPharm disclaims any obligation to update or revise its forward-looking statements, except as required by law.

More complete

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot